Global Direct-To-Consumer (DTC) Genetic Testing Market
HealthcareServices

Which Factors Will Push The Direct-To-Consumer (DTC) Genetic Testing Market To Achieve $3.87 Billion By 2029?

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Direct-To-Consumer (DTC) Genetic Testing Market In The Coming Years?

The market size of direct-to-consumer (dtc) genetic testing has seen a swift escalation in recent times. Its value is projected to rise from $1.84 billion in 2024 to $2.14 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 15.9%. Factors such as interest in lineage and genealogy, health and wellness movements, promotional activities and consumer awareness, confidentiality and oversight of genetic information, and cost effectiveness and easy availability, all contributed to its growth in the past.

Anticipated to experience swift escalation in the forthcoming years is the direct-to-consumer (dtc) genetic testing market size, predicted to surge to $3.87 billion in 2029 with a compound annual growth rate (CAGR) of 16.0%. Factors contributing to this projected growth include the diversification of test offerings, integration with custom-made medication, partnerships with health and wellness sectors, advances in genetic studies, and governmental backing and regulation. The forecast period is likely to see trends such as the broadening of test offerings and panels, awareness initiatives for customers, regulatory adherence and supervision, research and contributions in genomic data, and an overall decrease in costs and increase in availability.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8957&type=smp

Which Growth Drivers Are Shaping The Direct-To-Consumer (DTC) Genetic Testing Market Outlook?

The growth of the direct-to-consumer (DTC) genetic testing market is expected to be spurred on by the increasing occurrence of diseases and disorders that are genetically transmitted. A genetic disorder is a sickness brought about by mutations in a person’s DNA and incorporates single-gene, multifactorial, and chromosomal disorders. DTC genetic testing bolsters awareness about a variety of genetic disorders. This awareness aids in forecasting health trends and furnishes personalized information about an individual’s health, disease susceptibility and other characteristics. This information supports impactful healthcare and lifestyle choices that can mitigate disease susceptibility. For instance, the National Library of Medicine (NLM), a US medical library, reported in April 2023, that nearly 6.7 million Americans over the age of 65 will be afflicted with Alzheimer’s dementia (AD) in 2023, a disorder heavily influenced by genetics. If medical breakthroughs to prevent, slow or cure AD do not occur, this figure could increase to 13.8 million by 2060. As such, the mounting occurrence of diseases and disorders that are genetically transmitted is fueling the growth of the DTC genetic testing market.

What Is The Segment Breakdown Of The Direct-To-Consumer (DTC) Genetic Testing Market?

The direct-to-consumer (dtc) genetic testingmarket covered in this report is segmented –

1) By Type: Carrier Testing; Predictive Testing; Ancestry And Relationship Testing; Nutrigenomic Testing; Other Types

2) By Sample: Saliva; Urine; Blood

3) By Technology: Single Nucleotide Polymorphism Chips; Whole Genome Sequencing; Targeted Analysis

4) By Business Model: Health Planning Model; Comprehensive Genome Tests Model; Medical Precision Tests Model; Restricted Trait Tests Mode

5) By End User: Laboratories; Blood Banks; Nursing Homes; Hospitals; Imaging Centers; Home Care; Cosmetics; Other End-User

Subsegments:

1) By Carrier Testing: Autosomal Recessive Disorders; X-Linked Disorders

2) By Predictive Testing: Risk Assessment For Genetic Conditions; Adult-Onset Conditions

3) By Ancestry And Relationship Testing: Ancestry Composition Analysis; DNA Matching For Relationships

4) By Nutrigenomic Testing: Dietary Recommendations; Metabolism And Fitness Insights

5) By Other Types: Pharmacogenomic Testing; Health Trait Testing

What New Opportunities Are Emerging From Trends In The Direct-To-Consumer (DTC) Genetic Testing Market?

Leading firms in the direct-to-consumer (DTC) genetic testing market are emphasizing investment in genetic research to maintain their market dominance. These investments supply the essential financial support required for genetic testing firms to perform research, improve technology, broaden their market base, adhere to compliance, and fuel innovation. For instance, in November 2022, Redcliffe Labs, an Indian diagnostic centers & diagnosis labs, unveiled its plan to invest an extra $10 million (approximately Rs 81 crore) in the growth of its genetic and specialized testing range. The investment aims to advance the company’s genetic testing abilities, including sectors like prenatal, oncology, neurology, nephrology, and pharmacogenomics. The firm has already invested $6 million into genetic and specialized testing coverage and is concentrating on upcoming technologies in the diagnostic area.

Who Are The Major Stakeholders Operating In The Direct-To-Consumer (DTC) Genetic Testing Market?

Major companies operating in the direct-to-consumer (DTC) genetic testing market include 23andMe, AncestryDNA, MyHeritage, FamilyTreeDNA, Living DNA, Vitagene, Orig3n, DNAfit, Helix, Color Genomics, Circle DNA, CRI Genetics, MapMyGenome, Invitae Corporation, TellmeGen, Pathway Genomics, Genebase Systems, EasyDNA, Nebula Genomics, Dante Labs, Veritas Genetics, Xcode Life, Genomic Express, Genomelink, Genomind, WellnessFX, LetsGetChecked, iGene, Dnadoc, OneOme

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/direct-to-consumer-dtc-genetic-testing-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Direct-To-Consumer (DTC) Genetic Testing Market?

North America was the largest region in the direct-to-consumer (DTC) genetic testing market share in 2024. Asia-Pacific was the second-largest region in the global direct-to-consumer (DTC) genetic testing market. The regions covered in the direct-to-consumer (dtc) genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=8957&type=smp

Browse Through More Reports Similar to the Global Direct-To-Consumer (DTC) Genetic Testing Market 2025, By The Business Research Company

Healthcare Analytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

Automotive Testing Inspection And Certification Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

Cold Plasma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model